According to the deep-dive market assessment study by Growth+Reports, the global surgical sutures market peaked at ~US$ 3.9 billion in 2021. The market is expected to witness a CAGR of 5.4% from 2022 to 2030.
Lifestyle disorders like cancer, ischemic heart disease, cerebrovascular disease, orthopedic issues, and mental illness are becoming more and more common across the globe. The continual rise in the prevalence of lifestyle diseases and the rising need for more surgical procedures are driving the market for surgical sutures. The rapid increase in the elderly population and age-associated surgeries also augments the market. The majority of countries are expected to raise their healthcare spending, and rising economies are expected to strengthen their healthcare infrastructure. The success rate of surgery increases as a result of major industry players releasing items with cutting-edge technology that aid in more precise treatments. Consequently, this causes the market for surgical sutures to grow globally.
However, many side-effects associated with suturing such as suture scares, swelling due to infection, etc and the presence of alternatives like surgical staplers are some of the major challenges for the surgical sutures market growth.
The increasing number of surgical procedures like knee replacement, dental surgeries, hip replacement, bypass surgeries, cosmetic surgeries, etc. are in turn increasing the use of sutures to close the wounds at a faster pace. According to Aesthetic Plastic Surgery Statistics, 2021 data there were around 320 plastic surgeries performed in the United States which increased by 54%. This indicates that this factor is a major driving factor for the global surgical sutures market.
There is a worldwide increase in the geriatric population, indicating that age-associated surgeries such as knee replacement, organ transplant, etc require advanced suturing devices. According to a study by National Center for Biotechnology Information, U.S. it was estimated that around 30% of individuals suffer falls in old age in the United States every year. This increases the chances of knee replacement surgeries.
There is a growing focus on research and development activities to develop innovative products due to the increased awareness of surgical interventions. In July 2022, DURAMESHTM Suturable Mesh is being added to the pfm medical ag product line. For the first time, this ground-breaking suturable mesh combines the benefits of mesh reconstruction with the precise application of surgical sutures. When strong forces need to be conveyed, surgical sutures can be replaced by DURAMESHTM. Many companies are establishing their foot in the market by taking strategic steps such as mergers and acquisitions.
The Asia Pacific region is predicted to expand the fastest. The region's unmet healthcare needs, an aging population that is more prone to require surgery, and rising government investment in the healthcare system are the causes of this. Companies launching new products in the region is also contributing to the market expansion. For instance, Healthium Medtech launched a knotless tissue closure device- Tuborb, in order to shorten the suturing time. China, India, and Japan are a few of the significant marketplaces in the Asia Pacific region. The rise of medical tourism in countries like India, Singapore, and Malaysia is another important factor driving the industry in this sector toward exponential growth.
Some of the prominent players operating in the global surgical sutures market are B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic plcEthicon, Inc., Covidien plc, Sutures India Pvt Ltd, CONMED CORPORATION, Mellon Medical B.V., Smith & Nephew plc, Peters Surgical, Apollo Endosurgery, Inc. and EndoEvolution, LLC among others.